High materiality8/10
Scribe Therapeutics initiated with a Buy at Guggenheim
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Guggenheim initiates Buy on SCTX with a $50 target; current price $21.19; bullish setup.
- Guggenheim Buy on SCTX; PT $50; price $21.19.
Key facts
- 01
Target: $50
- 02
Posted price: $21.19
- 03
Analyst firm: Guggenheim
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.